Status:
COMPLETED
Use of Blood Flow Restriction Therapy Following ACL Tear
Lead Sponsor:
Henry Ford Health System
Conditions:
Anterior Cruciate Ligament Tear
Knee Injuries
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Evaluating the use of peri-operative blood flow restriction therapy surrounding anterior cruciate ligament tear
Detailed Description
The purpose of this study is to examine the effect of utilizing blood flow restriction (BFR) therapy both before and after anterior cruciate ligament reconstruction (ACLR) following a tear. BFR has be...
Eligibility Criteria
Inclusion
- ACL tear undergoing reconstruction
Exclusion
- History of pulmonary embolism
- History of deep vein thrombosis
- Family history of PE/DVT
- Hypercoaguable disorder
- Multiligamentous knee injury
- Neurovascular injury
- Peripheral vascular disease
- Unable to complete physical therapy
- Unable to tolerate blood flow restriction
Key Trial Info
Start Date :
July 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04374968
Start Date
July 28 2020
End Date
May 1 2022
Last Update
July 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Hospital
West Bloomfield, Michigan, United States, 48332